These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25414285)

  • 41. Doctors trial amiodarone for Ebola in Sierra Leone.
    Turone F
    BMJ; 2014 Nov; 349():g7198. PubMed ID: 25429872
    [No Abstract]   [Full Text] [Related]  

  • 42. Infectious disease. Combating emerging viral threats.
    Bekerman E; Einav S
    Science; 2015 Apr; 348(6232):282-3. PubMed ID: 25883340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug targets in infections with Ebola and Marburg viruses.
    Gene OG; Julia BE; Vanessa MR; Victoria WJ; Thomas GW; Lisa HE
    Infect Disord Drug Targets; 2009 Apr; 9(2):191-200. PubMed ID: 19275706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.
    Gupta M; MacNeil A; Reed ZD; Rollin PE; Spiropoulou CF
    Virology; 2012 Feb; 423(2):119-24. PubMed ID: 22197674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the Loop.
    Mire CE; Geisbert TW
    Trends Mol Med; 2017 Aug; 23(8):669-671. PubMed ID: 28697885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
    Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
    PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunology of protection from Ebola virus infection.
    Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF
    Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dose regimen of favipiravir for Ebola virus disease.
    Mentré F; Taburet AM; Guedj J; Anglaret X; Keïta S; de Lamballerie X; Malvy D
    Lancet Infect Dis; 2015 Feb; 15(2):150-1. PubMed ID: 25435054
    [No Abstract]   [Full Text] [Related]  

  • 49. A viewpoint on European Medicines Agency experience with investigational medicinal products for Ebola.
    Cavaleri M; Thomson A; Salmonson T; Hemmings RJ
    Clin Trials; 2016 Feb; 13(1):101-4. PubMed ID: 26768561
    [No Abstract]   [Full Text] [Related]  

  • 50. Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities.
    Fisher R; Borio L
    Microbiol Spectr; 2016 Jun; 4(3):. PubMed ID: 27337455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycofullerenes: Sweet fullerenes vanquish viruses.
    Vidal S
    Nat Chem; 2016 Jan; 8(1):4-6. PubMed ID: 26673255
    [No Abstract]   [Full Text] [Related]  

  • 52. Small molecule inhibitors of ebola virus infection.
    Picazo E; Giordanetto F
    Drug Discov Today; 2015 Feb; 20(2):277-86. PubMed ID: 25532798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomisation is essential in Ebola drug trials.
    Shaw D
    Lancet; 2014 Nov; 384(9955):1667. PubMed ID: 25441188
    [No Abstract]   [Full Text] [Related]  

  • 54. Prioritising Healthcare Workers for Ebola Treatment: Treating Those at Greatest Risk to Confer Greatest Benefit.
    Satalkar P; Elger BE; Shaw DM
    Dev World Bioeth; 2015 Aug; 15(2):59-67. PubMed ID: 25655050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ebolavirus's Foibles.
    Yamayoshi S; Kawaoka Y
    Cell; 2017 May; 169(5):773-775. PubMed ID: 28525748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Evaluation of Ebola Virus Disease Therapeutics.
    Liu G; Wong G; Su S; Bi Y; Plummer F; Gao GF; Kobinger G; Qiu X
    Trends Mol Med; 2017 Sep; 23(9):820-830. PubMed ID: 28822631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976.
    Hofmann-Winkler H; Gnirß K; Wrensch F; Pöhlmann S
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S172-80. PubMed ID: 25840443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viral Infections in Pregnancy: A Focus on Ebola Virus.
    Olgun NS
    Curr Pharm Des; 2018; 24(9):993-998. PubMed ID: 29384053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.
    Chinello P; Petrosillo N; Pittalis S; Biava G; Ippolito G; Nicastri E;
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006034. PubMed ID: 29283993
    [No Abstract]   [Full Text] [Related]  

  • 60. First Ebola virus vaccine to protect human beings?
    Geisbert TW
    Lancet; 2017 Feb; 389(10068):479-480. PubMed ID: 28017402
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.